Patents by Inventor Sonia Krivonos

Sonia Krivonos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ibrutinib solid forms and production process therefor
    Patent number: 10280173
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: May 7, 2019
    Assignee: WAVELENGTH ENTERPRISES LTD
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernandez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • IBRUTINIB SOLID FORMS AND PRODUCTION PROCESS THEREFOR
    Publication number: 20180251463
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Application
    Filed: December 22, 2017
    Publication date: September 6, 2018
    Applicant: WAVELENGTH ENTERPRISES LTD.
    Inventors: Itai ADIN, Sonia KRIVONOS, Yevgeny ROZENBLAT, Alex WEISMAN, Ana FERNANDEZ CASARES, Gloria TEN FIGAS, Revital BEN-DANIEL
  • Ibrutinib solid forms and production process therefor
    Patent number: 9884869
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: February 6, 2018
    Assignee: PERRIGO API LTD.
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernadez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • Crystalline rotigotine base and preparation process therefor
    Patent number: 8344165
    Abstract: An isolated and pure crystalline rotigotine base of polymorph Form I, and processes for producing the crystalline rotigotine base are disclosed. Also disclosed is a transdermal patch for the delivery of rotigotine base using the disclosed isolated and pure form of rotigotine base, which can be used in treatment of Parkinson's Disease and other disorders ameliorated or treated by rotigotine, including restless leg syndrome.
    Type: Grant
    Filed: May 28, 2008
    Date of Patent: January 1, 2013
    Assignee: CHEMAGIS Ltd.
    Inventors: Sonia Krivonos, Alex Weisman
  • CRYSTALLINE ROTIGOTINE BASE AND PREPARATION PROCESS THEREFOR
    Publication number: 20100222602
    Abstract: An isolated and pure crystalline rotigotine base of polymorph Form I, and processes for producing the crystalline rotigotine base are disclosed. Also disclosed is a transdermal patch for the delivery of rotigotine base using the disclosed isolated and pure form of rotigotine base, which can be used in treatment of Parkinson's Disease and other disorders ameliorated or treated by rotigotine, including restless leg syndrome.
    Type: Application
    Filed: May 28, 2008
    Publication date: September 2, 2010
    Applicant: CHEMAGIS LTD.
    Inventors: Sonia Krivonos, Alex Weisman
  • Process for producing highly pure midazolam and salts thereof
    Patent number: 7776852
    Abstract: Provided is a process for producing highly pure midazolam and salts thereof, and a pharmaceutical composition containing the highly pure midazolam and/or a salt thereof.
    Type: Grant
    Filed: September 11, 2007
    Date of Patent: August 17, 2010
    Assignee: CHEMAGIS Ltd.
    Inventors: Sonia Krivonos, Yana Sery
  • Imatinib production process
    Patent number: 7550591
    Abstract: Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: June 23, 2009
    Assignee: Chemagis Ltd.
    Inventors: Liu Xing, He Xungui, Yuan Wang, Michel Bekhazi, Sonia Krivonos, Edna Danon
  • PROCESS FOR PRODUCING HIGHLY PURE MIDAZOLAM AND SALTS THEREOF
    Publication number: 20090069306
    Abstract: Provided is a process for producing highly pure midazolam and salts thereof, and a pharmaceutical composition containing the highly pure midazolam and/or a salt thereof.
    Type: Application
    Filed: September 11, 2007
    Publication date: March 12, 2009
    Applicant: CHEMAGIS LTD.
    Inventors: Sonia KRIVONOS, Yana SERY
  • IMATINIB PRODUCTION PROCESS
    Publication number: 20080275055
    Abstract: Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt.
    Type: Application
    Filed: May 2, 2007
    Publication date: November 6, 2008
    Applicant: CHEMAGIS LTD.
    Inventors: Liu Xing, He Xungui, Yuan Wang, Michel Bekhazi, Sonia Krivonos, Edna Danon
  • STABLE AMORPHOUS IMATINIB MESYLATE AND PRODUCTION PROCESS THEREFOR
    Publication number: 20080234286
    Abstract: Provided herein is a spray dried stable amorphous imatinib mesylate as a free-flowing solid and process for producing the amorphous imatinib mesylate in highly pure form.
    Type: Application
    Filed: March 19, 2008
    Publication date: September 25, 2008
    Applicant: CHEMAGIS Ltd.
    Inventors: Alex Weisman, Sonia Krivonos, Edna Danon, Itai Adin, Carmen Iustain